First of all, we do use our market share, which is pretty large, to reduce prices and make those prices available to the countries that we serve, if you like. We have been able through procurement to reduce global prices, for example, for HIV drugs, by 25% over the last two years. That has cut in half almost the price we pay as the Global Fund, and that's a direct benefit for the countries, not only if they are supported by the Global Fund.
Second, we are working with countries on transitional plans, particularly, of course, middle-income countries. That means you must have a transition plan in place, because they cannot expect the Global Fund will fund them forever. They have to take over increasingly the costs, but they also need some time so that their ministries of finance can prepare for that. That's happening. We've phased out of a number of countries that can then finance the programs themselves. But you shouldn't stop overnight. You have to give them the chance to take that over. There's a whole kind of transition policy now that the Global Fund board has approved, with Canada's support actually, that I think helped to prepare for that phase. Fortunately, there are more and more countries whose per capita income is rising, and therefore they will take more responsibility for that. That enables us to focus even more on the fragile states that for some time to come will still need this international support.